SEC Filing Details

Document Details

Form
4
Filing Date
Mar 26, 2024
Document Date
Mar 25, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Cumberland Pharmaceuticals, Inc.
Issuer
CUMBERLAND PHARMACEUTICALS INC